Grail, Inc. (NL0)
XDUS
Real-time Data
06:00 AM
Day's Range
67.6252 wk Range
26.80Overview - NL0 - Grail, Inc.
Key Statistics
Valuation
Enterprise Value
806.95M
P/E (Trailing)
‪-6.07‬
PEG Ratio
‪0.31‬
Price / Sales (TTM)
‪18.24‬
Price / Book
‪1.21‬
EV / EBITDA
‪-2.48‬
Profitability
Gross Margin
‪-28.12%‬
Profit Margin
‪-236.94%‬
Operating Margin
‪-331.99%‬
Return on Assets
‪-12.03%‬
Return on Equity
‪-16.12%‬
Ownership
Shares Outstanding
44.66M
Float
34.28M
Held by Insiders
‪5.02%‬
Held by Institutions
‪86.79%‬
Price stats
Beta
‪3.24‬
50-Day Avg
‪60.02‬
200-Day Avg
‪61.92‬
Market Cap - NL0 - Grail, Inc.
Profile Summary - NL0 - Grail, Inc.
About
GRAIL, Inc. is a healthcare biotechnology company focused on early cancer detection. The company develops and commercializes blood-based screening products designed to identify signals from multiple cancer types before symptoms appear, supporting earlier clinical follow-up and diagnosis. Its primary offering, Galleri,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
